About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Integrating Modern Tech with Drupal
Organizations across industries are under immense pressure to scale their digital ecosystems efficiently while maintaining consistency and delivering seamless customer experiences. For enterprises…
|
Your Guide to Build Scalable Drupal Websites
Scalability is not just a buzzword—it's a necessity for organizations managing complex digital ecosystems. Whether you're a financial institution overseeing multiple regional websites or a…
|
Your Path to Drupal 9 and Beyond
Your Path to Drupal 9 and Beyond: What's in the Hood?The digital landscape is undergoing a seismic shift, and organizations face increasing pressure to adapt. For enterprises reliant on Drupal,…
|
Essential Features of Drupal 9 for Developers
Introduction to Drupal 9 and its End of LifeDrupal 9 is an open-source content management system (CMS) widely used for building websites and web applications. It's known for its flexibility,…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
